1. Umbilical cord mesenchymal stromal cell transplantations: A systemic analysis of clinical trials
   Alp Can et al, 2017, Cytotherapy CrossRef
2. Allogeneic transplantation of mobilized dental pulp stem cells with the mismatched dog leukocyte antigen type is safe and efficacious for total pulp regeneration
   Koichiro Iohara et al, 2018, Stem Cell Res Ther CrossRef
3. Characteristics and clinical applications of Wharton’s jelly-derived mesenchymal stromal cells
   L.L. Liau et al, 2019, Current Research in Translational Medicine CrossRef
4. Three-Dimensional Culture of Umbilical Cord Mesenchymal Stem Cells Effectively Promotes Platelet Recovery in Immune Thrombocytopenia
   Xiangcui Gong et al, 2020, Biological & Pharmaceutical Bulletin CrossRef
5. miRNA-98-5p Targeting IGF2BP1 Induces Mesenchymal Stem Cell Apoptosis by Modulating PI3K/Akt and p53 in Immune Thrombocytopenia.
   Yanan Wang et al, 2020, Mol Ther Nucleic Acids CrossRef
6. Role of bone marrow‐derived mesenchymal stem cell defects in CD8 + CD28 – suppressor T‐lymphocyte induction in patients with immune thrombocytopenia and associated mechanisms
   Huiyuan Li et al, 2020, Br J Haematol CrossRef
7. Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells Maintains and Partially Improves Visual Function in Patients with Advanced Retinitis Pigmentosa
   Tongtao Zhao et al, 2020, Stem Cells and Development CrossRef
8. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance via PTEN-mediated crosstalk between the PI3K/Akt and Erk/MAPKs signaling pathways in the skeletal muscles of db/db mice
   Guang Chen et al, 2020, Stem Cell Res Ther CrossRef
9. Current Status and Future Prospects of Perinatal Stem Cells
   Paz de la Torre et al, 2020, Genes CrossRef
10. Insights on chronic immune thrombocytopenia pathogenesis: A bench to bedside update
    José Carlos Jaime-Pérez et al, 2021, Blood Reviews CrossRef
11. The Extensive Regulation of MicroRNA in Immune Thrombocytopenia
    Yuerong Zhao et al, 2022, Clin Appl Thromb Hemost CrossRef
12. The Mechanistic Effects and Clinical Applications of Various Derived Mesenchymal Stem Cells in Immune Thrombocytopenia
    Yue He et al, 2022, Acta Haematol CrossRef
13. Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
    Yue Lv et al, 2022, Front. Immunol. CrossRef
14. Therapeutic potential of MSCs and MSC-derived extracellular vesicles in immune thrombocytopenia
    Feifeng Wu et al, 2023, Stem Cell Res Ther CrossRef
15. Knowledge mapping of immune thrombocytopenia: a bibliometric study
    Feifeng Wu et al, 2023, Front. Immunol. CrossRef
16. Characterization of dynamical changes in vital signs during allogeneic human umbilical cord-derived mesenchymal stem cells infusion
    Yue Wang et al, 2023, Regenerative Therapy CrossRef
17. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial
    Yunfei Chen et al, 2024, Sig Transduct Target Ther CrossRef
18. Multipotent mesenchymal stromal/stem cell-based therapies for acute respiratory distress syndrome: current progress, challenges, and future frontiers
    M. Sababathy et al, 2024, Braz J Med Biol Res CrossRef